drugset / Trial / NCT01318252
AL-54478 Proof of Concept Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL-54478 | Unknown | 0.005 % | — |
| Comparator | Latanoprost | Small molecule | 0.005 % | — |